Literature DB >> 9643059

A longitudinal analysis of eye tracking dysfunction and attention in recent-onset schizophrenia.

C M Yee1, K H Nuechterlein, M E Dawson.   

Abstract

The effect of an attentional manipulation on eye tracking dysfunction (ETD) in the early stages of schizophrenia was examined in 34 recent-onset schizophrenic patients and 24 demographically matched normal subjects over a 1-year period. An attentional enhancement manipulation improved eye tracking performance of recent-onset schizophrenic patients more than that of normal subjects. Eye tracking level also was moderately stable for both groups over the course of 1 year. The possible role of attentional allocation in ETD highlights the need for further examination of the interface between attentional and eye tracking measures of vulnerability to schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9643059

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  4 in total

1.  Neurobehavioral abnormalities in first-degree relatives of individuals with autism.

Authors:  Matthew W Mosconi; Margaret Kay; Anna-Maria D'Cruz; Stephen Guter; Kush Kapur; Carol Macmillan; Lisa D Stanford; John A Sweeney
Journal:  Arch Gen Psychiatry       Date:  2010-08

2.  Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia.

Authors:  Cindy M Yee; Terrance J Williams; Patricia M White; Keith H Nuechterlein; Donna Ames; Kenneth L Subotnik
Journal:  J Abnorm Psychol       Date:  2010-02

3.  Neural mechanisms of smooth pursuit eye movements in schizotypy.

Authors:  Inga Meyhöfer; Maria Steffens; Anna Kasparbauer; Phillip Grant; Bernd Weber; Ulrich Ettinger
Journal:  Hum Brain Mapp       Date:  2014-09-05       Impact factor: 5.038

Review 4.  The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders.

Authors:  Matthew W Mosconi; Zheng Wang; Lauren M Schmitt; Peter Tsai; John A Sweeney
Journal:  Front Neurosci       Date:  2015-09-01       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.